XML 98 R7.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
OPERATING ACTIVITIES      
Net (loss) income $ (87,111) $ 175,402 $ 162,511
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation, amortization and other non-cash charges 172,607 166,789 166,558
Stock-based compensation expense 8,630 9,419 11,090
Gain on disposition of assets, net 2,645 3,344 4,530
Gain due to insurance recovery   (9,646)  
Gain due to benefit plan financing arrangement (126) (1,020)  
Deferred income tax (benefit) provision (22,225) 21,395 (42,609)
Impairment and other charges, net 73,560    
(Increase) decrease in assets:      
Accounts receivable 81,094 53,982 (208,642)
Income taxes receivable 11,687 4,410 16,931
Inventories 20,962 (15,660) (6,275)
Prepaid expenses (692) (778) (2,272)
Other current assets 300 3,375 (1,222)
Other non-current assets (3,024) 1,494 (4,779)
Increase (decrease) in liabilities:      
Accounts payable (42,241) (7,754) 29,176
Income taxes payable (3,172) 1,482 (1,705)
Accrued payroll and related expenses (6,103) 2,193 11,408
Accrued insurance expenses 1,357 884 1,200
Accrued state, local and other taxes (654) (5,574) 5,561
Other accrued expenses (2,089) (994) (5,335)
Pension liabilities 6,575 (7,862) 4,398
Long-term accrued insurance expenses 1,968 1,696 839
Other long-term liabilities 483 (880) 1,401
Net cash provided by operating activities 209,141 389,009 133,704
INVESTING ACTIVITIES      
Capital expenditures (250,629) (242,610) (117,509)
Proceeds from sale of assets 14,841 13,237 13,123
Proceeds from insurance recovery   9,646  
Proceeds from benefit plan financing arrangement 507 2,218  
Re-investment in benefit plan financing arrangement (507) (2,218)  
Net cash used for investing activities (235,788) (219,727) (104,386)
FINANCING ACTIVITIES      
Payment of dividends (32,231) (101,069) (43,319)
Cash paid for common stock purchased and retired (7,361) (43,001) (26,784)
Net cash used for financing activities (39,592) (144,070) (70,103)
Net (decrease) increase in cash and cash equivalents (66,239) 25,212 (40,785)
Cash and cash equivalents at beginning of year 116,262 91,050 131,835
Cash and cash equivalents at end of year $ 50,023 $ 116,262 $ 91,050